Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Globulin Stories

2013-07-10 08:27:00

TEMECULA, Calif., July 10, 2013 /PRNewswire-iReach/ -- Golden West Biologicals, Inc. (GWB) is pleased to announce that it will be exhibiting at the Clinical Lab Expo, hosted by the American Association for Clinical Chemistry, at the George R. Brown Convention Center in Houston, Texas, from July 30th to August 1st. (Photo: http://photos.prnewswire.com/prnh/20130710/CG44837) GWB has been a leading supplier and manufacturer of high quality biological products for the development of...

2012-07-30 22:20:55

TEMECULA, Calif., July 31, 2012 /PRNewswire-iReach/ -- Golden West Biologicals, Inc. is pleased to announce that it will be exhibiting at the UCSD Biotechnology Vendor Showcase(TM) 2012 spring show, at the University of California, San Diego in the Price Center West, Ballroom. The showcase is Thursday, August 23rd, 2012 from 10:00 a.m. to 2:30 p.m. Golden West Biologicals (GWB) has been a leading supplier and manufacturer of high quality biological products for the development of...

2012-07-17 02:27:47

TEMECULA, Calif., July 17, 2012 /PRNewswire-iReach/ -- Golden West Biologicals, Inc. (GWB) is pleased to announce the introduction of Seratrol Vitamin D Free Human Serum for use as reference material in the development of assays and calibrators. "It's important for in vitro diagnostic device manufacturers to deliver properly calibrated Vitamin D assays," said Tammy Guenthner, Manufacturing Manager at GWB. "Our Seratrol Vitamin D Free Human Serum product line has been developed to...

2012-07-13 02:22:32

TEMECULA, Calif., July 13, 2012 /PRNewswire-iReach/ -- Golden West Biologicals, Inc. is pleased to announce that it will be exhibiting at the Clinical Lab Expo, hosted by the American Association for Clinical Chemistry, at the Los Angeles Convention Center in Los Angeles, CA, from July 17 to 19. Golden West Biologicals (GWB) has been a leading supplier and manufacturer of high quality biological products for the development of immunoassays since 1989. This marks the 10th year that GWB will...

a0851966f0e2294e8432eaa5de6c93c91
2010-05-20 11:08:50

Scientists in Brazil are reporting for the first time that coffee beans contain proteins that can kill insects and might be developed into new insecticides for protecting food crops against destructive pests. Their study, which suggests a new use for one of the most important tropical crops in the world, appears in ACS' Journal of Agricultural and Food Chemistry, a bi-weekly publication. Peas, beans and some other plant seeds contain proteins, called globulins, which ward off insects. Coffee...

3a0eeb2a9b1a10c9067a097dbbfc9fbd1
2010-03-31 13:33:49

Scientists in Brazil are reporting for the first time that coffee beans contain proteins that can kill insects and might be developed into new insecticides for protecting food crops against destructive pests. Their study, which suggests a new use for one of the most important tropical crops in the world, appears in ACS' Journal of Agricultural and Food Chemistry, a bi-weekly publication. Peas, beans and some other plant seeds contain proteins, called globulins, which ward off insects. Coffee...

2009-09-23 08:49:00

LACHEN, SWITZERLAND and HOBOKEN, N.J., Sept. 23 /PRNewswire/ -- Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can...

2009-08-11 09:50:00

ANNAPOLIS, Md., Aug. 11 /PRNewswire/ -- The Plasma Protein Therapeutics Association (PPTA) supports the favorable recommendation of average sales price (ASP) + 6 percent for reimbursement of separately paid drugs and biologics in the hospital outpatient setting made by the Centers for Medicare and Medicaid Services' (CMS) Advisory Panel on Ambulatory Payment Classification (APC) at its August 5-7 meeting, although third party data maintains that ASP +12 percent is the appropriate...

2007-03-13 15:01:18

LOS ANGELES, March 13 /PRNewswire/ -- Today, global biopharmaceutical company Grifols SA, announced the decision of its Executive Committee to validate the "MiniFrac" Facility which will provide additional capacity thereby allowing the company to increase the overall plasma throughput at its Los Angeles manufacturing complex by as much as 700,000 liters. This will result in increased production of Grifols' proprietary hemophilia therapies, immune globulins, and albumin. Grifols management...